The United States Food and Drug Administration (FDA) refused a license for a latest weight-loss drug. The drug in question – Lorcaserin – was deemed not yet ready for approval. It seems the FDA has concerns about Lorcaserin’s effectiveness and its potential risk in increasing cancer in users. Apparently, there were higher than normal cases […]